Remdesivir is the only drug so far that has been shown to help patients with COVID-19, but Gilead and other companies are looking for ways to make it work better. For critically ill patients, Roche and Eli Lilly and Co are testing drugs in combination with remdesivir. Gilead is also seeking to treat the virus earlier.
